| Dr Jeffrey Allan Titcher, PSYD | |
|
1911 Williams Dr, #150, Oxnard, CA 93036-2612 | |
| (805) 981-8473 | |
| (805) 981-8461 |
| Full Name | Dr Jeffrey Allan Titcher |
|---|---|
| Gender | Male |
| Speciality | Psychologist - Clinical |
| Location | 1911 Williams Dr, Oxnard, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497871131 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | PSY20442 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffrey Allan Titcher, PSYD 1911 Williams Dr, #150, Oxnard, CA 93036-2612 Ph: (805) 981-8473 | Dr Jeffrey Allan Titcher, PSYD 1911 Williams Dr, #150, Oxnard, CA 93036-2612 Ph: (805) 981-8473 |
News Archive
In many countries, there are strict regulations and inspections regarding workers who handle chemotherapy drugs. "In the U.S., however, neither environmental monitoring nor exposure tracking is mandated. And neither is routinely taking place, said Tom Conner, a research biologist with National Institute for Occupational Safety and Health (NIOSH).
Hospitalization for underage drinking is common in the United States, and it comes with a price tag — the estimated total cost for these hospitalizations is about $755 million per year, a Mayo Clinic study has found. Researchers also found geographic and demographic differences in the incidence of alcohol-related hospital admissions.
Amgen Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has announced a positive opinion for the marketing authorization of Prolia((TM)) (denosumab) for the treatment of osteoporosis in postmenopausal women at increased risk of fractures, and for the treatment of bone loss associated with hormone ablation in men with prostate cancer at increased risk of fractures.
Inhibitex, Inc. today reported top-line safety and efficacy data from its Phase II clinical trial of FV-100, an oral antiviral compound being developed to treat herpes zoster, more commonly referred to as shingles. The study was the first clinical trial to assess the antiviral activity of FV-100, included 350 shingles patients and compared two once-daily doses of FV-100 (200 mg and 400 mg) to an active control, valacyclovir, one of the most commonly-used antiviral drugs to treat shingles.
› Verified 5 days ago
Melissa Buttner, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1690 Universe Cir, Oxnard, CA 93033 Phone: 310-478-3711 | |
Dr. Serena Bezdjian, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1911 Williams Dr, Oxnard, CA 93036 Phone: 818-590-3031 | |
Dr. Trudy Gilbert, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 300 E Esplanade Dr, Suite 900, Oxnard, CA 93036 Phone: 805-832-8536 | |
Dr. Patricia Louise Wood, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 500 E Esplanade Dr, Suite 860, Oxnard, CA 93036 Phone: 805-375-8382 | |
Patti Michaels, M.A. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1911 Williams Dr, Ventura County Older Adult Services Ste 165, Oxnard, CA 93036 Phone: 805-272-5900 Fax: 805-981-5411 | |
Brigitte Wilburg, Psychologist Medicare: Medicare Enrolled Practice Location: 450 W Clara St, Oxnard, CA 93033 Phone: 805-488-0210 Fax: 805-488-0510 | |
James P Cole, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 993 West 7th St, Oxnard, CA 93030 Phone: 805-483-9565 Fax: 805-486-5483 |